Shivalik Rasayan Limited
  • Home
  • About Us
    • Overview
      • Mission and Values
    • Our History
    • Chairman's Message
    • Leadership Team
    • The Board at SRL
    • CSR
  • Business Units
    • Pharmaceuticals
      • Active Pharmaceutical Ingredients
    • R&D Centre
    • Agrochemical
    • Speciality Chemicals
    • Intellectual Property
  • Focus Areas
    • API Manufacturing
    • Custom Manufacturing
    • Specialty Chemicals
    • Custom R&D
  • Products
    • Pharmaceuticals
      • ONCOLOGY
      • NON ONCOLOGY
    • Agrochemical
    • IPR
  • Investors
    • Investor Overview
    • Disclosures under Regulation 46
      • Annual Reports
      • Financial Results
    • Corporate Governance
    • Shareholding Pattern
    • Notices & Announcements
    • Policies
    • Investor Presentations
  • News
  • Careers
  • Contact
  • Get in Touch
Home / News

Shivalik Rasayan Limited – Corporate Update

Latest Updates Published August 29, 2018 Team SRL
Shivalik Rasayan Limited – Corporate Update

Shivalik Rasayan Limited continues to strengthen its pharmaceutical and agrochemical operations with a focus on quality, innovation and sustainable growth.

Share this article

Back to News

Recent Updates

  • Jul 15, 2022 Up-coming Agro-chemicals, synthetic Organic Chemicals & Intermediates plant at Dahej-III, Gujarat
  • Jul 14, 2022 SRL granted CEP for Busulfan, Clonidine HCl, Pirfenidone and Temozolomide
  • Jul 14, 2022 SRL submits first US Drug Master File for Bortezomib to USFDA
  • Apr 10, 2019 Dr. Vimal Kumar Shrawat, Industry veteran, joins SRL as Managing Director
Shivalik Rasayan Limited

Shivalik Rasayan Ltd — improving health and crop protection through innovative, regulatory-compliant chemistry.

Recent Post

  • About
  • Products
  • Quality
  • News
  • Contact

Project

  • SRL files process patent for Temozolomide
  • Shivalik Rasayan Limited – Corporate Update
  • Dr. Vimal Kumar Shrawat, Industry veteran, joins SRL as Managing Director
  • SRL granted CEP for Busulfan, Clonidine HCl, Pirfenidone and Temozolomide

Newsletter

Subscribe for company updates and industry insights.

Please enter a valid email address.
12 + 6 =
Please answer the security question correctly.
Enter the result of the math question.

© Shivalik Rasayan Limited. All rights reserved.

Designed by www.ezwebapp.com

Privacy Policy | Terms and Conditions